"The Charity is a non-profit-making organisation whose aim is to enhance awareness of Low Dose Naltrexone (LDN), and the promotion and funding of research and clinical trials of LDN as a treatment for Multiple Sclerosis and other autoimmune diseases. The results of such research will be published for the benefit of the public.
We need to raise funds to get clinical trials underway, starting with those for Multiple Sclerosis, and then for other diseases suggested by Dr Bernard Bihari which might benefit from trials of LDN.
Our ultimate goal is for everyone to be prescribed LDN on the NHS for all conditions where LDN could be of benefit.".
